How Hospitals Cope When a Drug Runs Out

How do hospitals manage drug shortages? Not by scrambling, at least not the good ones. The health systems that handle shortages well treat them as a standing operational problem with a team, a playbook, and a stockpile, not as a surprise. Five moves separate the hospitals that ride out a shortage from the ones that cancel procedures.

A shortage rarely announces itself politely. A wholesaler allocation email arrives, the pharmacy's on-hand count drops into the red, and suddenly a drug the ICU uses every day is unobtainable. What happens next depends on decisions the hospital made months or years earlier.

The shortage team exists before the shortage

The foundation is a standing multidisciplinary team. Pharmacy Times, summarizing the mitigation literature, describes these teams as typically including pharmacy leadership, clinicians, nursing, supply chain staff, and informatics specialists. Their job is to monitor supply status, anticipate disruptions, evaluate alternatives, and coordinate the institutional response. Clear policies let them make fast decisions during a critical shortage instead of convening a committee while the shelves empty.

That team maintains a simple but powerful artifact: a list of the hospital's most-used drugs mapped against the FDA and ASHP shortage lists, watched continuously. Life-sustaining therapies get extra scrutiny. When a shortage hits, the team is not discovering the problem. It is executing a plan it already wrote.

Substitution is a clinical operation, not a swap

When the preferred drug is gone, the move is therapeutic substitution: a different drug that treats the same condition. Done badly, this is where patients get hurt. Done well, it runs through clinical decision tools and standardized treatment pathways so every prescriber gets the same alternative, the same dose conversion, and the same protocol adjustment. Pharmacy Times notes that many hospitals embed shortage alerts and substitution guidance directly into the electronic health record, so the guidance appears at the moment of ordering. Pharmacist review of orders becomes especially important in high-risk areas like oncology, anesthesia, and intensive care.

One of the cleverest conservation moves is converting intravenous drugs to oral versions when clinically appropriate. IV formulations are disproportionately the ones in shortage, and a patient who can swallow a pill does not need the scarce injectable. Repackaging and allocation protocols stretch limited supplies across the patient population equitably, so one unit does not burn through the stock while another runs dry.

Inventory is a strategy, not a storeroom

The hospitals that weather shortages buy their way out of the panic in advance. Beth Israel Lahey Health runs a centralized services center that consolidates inventory, including safety stock, across its 14 hospitals and distributes from the hub. Its pharmacy supply chain director described the goal as extending the runway: having enough physical stock of drugs with histories of interruption, or with limited alternatives, to ride out the gap. Centralized purchasing also means the system sees the shortage coming in its own data before any single hospital feels it.

Relationships matter as much as stock. The senior pharmacy director at University of Missouri Health Care advises investing in secondary wholesalers and gray-market vendors with the same energy hospitals put into their primary wholesaler relationship, and empowering buyers to purchase from those secondary sources without a gauntlet of internal approvals. Supply dries up fast at the start of a shortage. The hospitals that move first get the stock. Enrolling in strategic reserve programs through group purchasing organizations adds another layer of protection.

Underneath all of it, stewardship committees are formalizing the discipline: dedicated shortage committees, demand planning on essential-medications lists, and standardized metrics for tracking supply problems. The era of each hospital improvising alone is ending.

What this means for patients

Most of this machinery is invisible to patients, and that is by design. But two things are worth knowing. First, if your prescription changes during a shortage, the substitution was almost certainly reviewed by a pharmacist and matched to a protocol. Ask your doctor or pharmacist what changed and why, and you will usually get a straight answer. Second, shortages are tracked publicly. The FDA maintains a current shortage list, and you can check which drugs are in shortage right now here. Knowing a shortage exists before your refill appointment turns a surprise into a plan.

Frequently asked questions

What is a drug shortage management team?

A standing hospital committee, usually led by pharmacy with clinicians, nursing, supply chain, and informatics staff, that monitors drug supplies, anticipates shortages, evaluates alternative therapies, and coordinates the response. The best ones meet regularly even when no shortage is active.

What is therapeutic substitution?

Replacing an unavailable drug with a different drug that treats the same condition safely and effectively. Hospitals run substitutions through standardized protocols with dose conversions and electronic health record alerts, plus pharmacist review, to keep the swap safe.

Why do hospitals switch IV drugs to pills during shortages?

Injectable drugs are disproportionately affected by shortages, and an oral version of the same therapy often exists. When clinically appropriate, converting eligible patients to oral therapy reduces demand for the scarce IV product and reserves it for patients who truly cannot take pills.

What is a strategic reserve program for drugs?

Programs, often run through group purchasing organizations, that let health systems build buffer stock of essential medications likely to face shortages. Combined with centralized inventory hubs, reserves give a hospital weeks of runway when a manufacturer's supply stops.

What should I do as a patient if my drug is in shortage?

Talk to your doctor or pharmacist before your refill runs out. Ask whether an alternative is appropriate, whether a different pharmacy has stock, and whether a compounding pharmacy can help. Check the FDA shortage list so you walk in informed rather than surprised.